Vca-894A
Neuromuscular Diseases (Nmd), Charcot Marie Tooth Disease (Cmt)
Phase I/II
Active Not Recruiting
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Oct 27, 2025
―
Iloperidone
Uncontrolled Hypertension, Hypertension
Phase II
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
Jul 22, 2025
―
Trichostatin A
Onychomycosis Of Toenail
Phase II
Active Not Recruiting
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
Jun 05, 2025
―
Iloperidone
Schizophrenia
Phase III
Recruiting
Randomized Withdrawal Study in Patients With Schizophrenia
Apr 29, 2025
―
Tasimelteon Oral Suspension
Insomnia Disorder
Phase III
Recruiting
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Apr 01, 2025
―
Milsaperidone
Major Depressive Disorder (Mdd)
Phase III
Recruiting
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Feb 11, 2025
―
Vhx-896
Healthy
Phase I
Completed
Food Effect Study of VHX-896 in Healthy Volunteers
Jan 27, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vanda Pharmaceuticals Inc. (VM4) have in its pipeline
VM4 is currently developing the following drugs: Ponesimod, Vca-894A, Vqw-765. These drug candidates are in various stages of clinical development as the company works toward FDA approval.